# LPHYSIO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lphysio

- Headquarters: Seoul, South Korea
- Website: www.lphysio.co.kr/
- Total disclosed funding: $0.1M
- Latest round: Seed (Jan 5, 2026)
- Investors on record: 2

## About

Based in South Korea, LPHYSIO is a medical technology company focused on providing advanced physiotherapy and rehabilitation solutions to healthcare professionals and patients through innovative equipment and software. LPHYSIO, founded in 2020 and headquartered in Seoul, South Korea, specializes in advanced physiotherapy solutions. The company has engaged in two funding deals, raising KRW 300 million in venture funding from returning investor Star Asset Partners in March 2026.

LPHYSIO specializes in the development and delivery of advanced physiotherapy and rehabilitation solutions, tailored to the needs of healthcare professionals and patients. The company's core product offerings include innovative therapeutic equipment and software systems designed to enhance treatment efficacy and streamline clinical workflows, addressing challenges such as patient engagement, progress tracking, and optimization of treatment protocols. LPHYSIO serves a diverse clientele including hospitals, rehabilitation centers, and outpatient clinics across Asia and Europe, providing tools to effectively manage and support patients' recovery processes. 

LPHYSIO generates revenue through direct sales and partnerships with healthcare institutions, employing a B2B model for distributing their products. Revenue streams are primarily derived from the sales of flagship therapeutic devices and subscription-based access to software solutions, which offer ongoing support and updates. Transactions typically occur through contracts with healthcare providers, allowing institutions to purchase equipment and enroll in software services tailored to their operational needs. Pricing reflects the value of technology delivered, with specific packages designed for varying scales within the rehabilitation sector, ensuring long-term client relationships that promote steady revenue flow while enhancing patient care outcomes.

## Funding rounds

- Seed, Jan 5, 2026, $0.1M — Y&ARCHER, Star Asset Partners

## Investors

- Y&ARCHER (https://capitalatlas.ai/funds/y-archer) — Seed
- Star Asset Partners (https://capitalatlas.ai/funds/star-asset-partners) — Seed